• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用稳健秩聚合鉴定细胞周期相关竞争性内源性RNA作为肺腺癌的预后生物标志物

Characterization of Cell Cycle-Related Competing Endogenous RNAs Using Robust Rank Aggregation as Prognostic Biomarker in Lung Adenocarcinoma.

作者信息

Yang Yifei, Zhang Shiqi, Guo Li

机构信息

Department of Bioinformatics, Smart Health Big Data Analysis and Location Services Engineering Lab of Jiangsu Province, School of Geographic and Biologic Information, Nanjing University of Posts and Telecommunications, Nanjing, China.

Department of Biology, Brandeis University, Waltham, MA, United States.

出版信息

Front Oncol. 2022 Feb 3;12:807367. doi: 10.3389/fonc.2022.807367. eCollection 2022.

DOI:10.3389/fonc.2022.807367
PMID:35186743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8853726/
Abstract

Lung adenocarcinoma (LUAD), one of the most common pathological subtypes in lung cancer, has been of concern because it is the leading cause of cancer-related deaths. Due to its poor prognosis, to identify a prognostic biomarker, this study performed an integrative analysis to screen curial RNAs and discuss their cross-talks. The messenger RNA (mRNA) profiles were primarily screened using robust rank aggregation (RRA) through several datasets, and these deregulated genes showed important roles in multiple biological pathways, especially for cell cycle and oocyte meiosis. Then, 31 candidate genes were obtained integrating 12 algorithms, and 16 hub genes (containing homologous genes) were further screened according to the potential prognostic values. These hub genes were used to search their regulators and biological-related microRNAs (miRNAs). In this way, 10 miRNAs were identified as candidate small RNAs associated with LUAD, and then miRNA-related long non-coding RNAs (lncRNAs) were further obtained. In-depth analysis showed that 4 hub mRNAs, 2 miRNAs, and 2 lncRNAs were potential crucial RNAs in the occurrence and development of cancer, and a competing endogenous RNA (ceRNA) network was then constructed. Finally, we identified CCNA2/MKI67/KIF11:miR-30a-5p:VPS9D1-AS1 axis-related cell cycle as a prognostic biomarker, which provided RNA cross-talks among mRNAs and non-coding RNAs (ncRNAs), especially at the multiple isomiR levels that further complicated the coding-non-coding RNA regulatory network. Our findings provide insight into complex cross-talks among diverse RNAs particularly involved in isomiRs, which will enrich our understanding of mRNA-ncRNA interactions in coding-non-coding RNA regulatory networks and their roles in tumorigenesis.

摘要

肺腺癌(LUAD)是肺癌中最常见的病理亚型之一,因其是癌症相关死亡的主要原因而备受关注。由于其预后较差,为了确定一种预后生物标志物,本研究进行了综合分析以筛选关键RNA并探讨它们之间的相互作用。通过稳健秩聚合(RRA)方法,利用多个数据集初步筛选信使RNA(mRNA)谱,这些失调基因在多个生物学途径中发挥重要作用,尤其是在细胞周期和卵母细胞减数分裂方面。然后,整合12种算法获得31个候选基因,并根据潜在预后价值进一步筛选出16个核心基因(包括同源基因)。利用这些核心基因搜索其调控因子和生物学相关的微小RNA(miRNA)。通过这种方式,鉴定出10个miRNA作为与LUAD相关的候选小RNA,随后进一步获得与miRNA相关的长链非编码RNA(lncRNA)。深入分析表明,4个核心mRNA、2个miRNA和2个lncRNA是癌症发生发展过程中的潜在关键RNA,并构建了一个竞争性内源性RNA(ceRNA)网络。最后,我们确定CCNA2/MKI67/KIF11:miR-30a-5p:VPS9D1-AS1轴相关的细胞周期作为一种预后生物标志物,它提供了mRNA和非编码RNA(ncRNA)之间的RNA相互作用,特别是在多个异源miR水平上,这进一步使编码-非编码RNA调控网络复杂化。我们的研究结果为不同RNA之间复杂的相互作用提供了见解,特别是涉及异源miR的相互作用,这将丰富我们对编码-非编码RNA调控网络中mRNA-ncRNA相互作用及其在肿瘤发生中的作用的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/55f0b02e6b26/fonc-12-807367-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/133e28be6e33/fonc-12-807367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/13e17d3fd9ea/fonc-12-807367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/beba18c8994f/fonc-12-807367-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/3d303b0c060a/fonc-12-807367-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/5061ca5eb4ff/fonc-12-807367-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/4e26ef582f95/fonc-12-807367-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/55f0b02e6b26/fonc-12-807367-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/133e28be6e33/fonc-12-807367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/13e17d3fd9ea/fonc-12-807367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/beba18c8994f/fonc-12-807367-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/3d303b0c060a/fonc-12-807367-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/5061ca5eb4ff/fonc-12-807367-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/4e26ef582f95/fonc-12-807367-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bca/8853726/55f0b02e6b26/fonc-12-807367-g007.jpg

相似文献

1
Characterization of Cell Cycle-Related Competing Endogenous RNAs Using Robust Rank Aggregation as Prognostic Biomarker in Lung Adenocarcinoma.使用稳健秩聚合鉴定细胞周期相关竞争性内源性RNA作为肺腺癌的预后生物标志物
Front Oncol. 2022 Feb 3;12:807367. doi: 10.3389/fonc.2022.807367. eCollection 2022.
2
Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma.蛋白质谱分析揭示了胆管癌中RNA之间潜在的与异源微小RNA相关的相互作用。
Comput Struct Biotechnol J. 2021 Oct 14;19:5722-5734. doi: 10.1016/j.csbj.2021.10.014. eCollection 2021.
3
Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.三种新型竞争性内源性 RNA 生物标志物在肺腺癌中具有预后价值的综合分析。
Biomed Res Int. 2020 Aug 4;2020:2837906. doi: 10.1155/2020/2837906. eCollection 2020.
4
Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in Lung Adenocarcinoma.构建并分析肺腺癌中与生存相关的竞争性内源性 RNA 网络。
Biomed Res Int. 2021 Feb 11;2021:4093426. doi: 10.1155/2021/4093426. eCollection 2021.
5
Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.基于异常 lncRNA-miRNA-mRNA 网络和 Cox 回归模型的肺腺癌预后生物标志物的综合分析。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20191554.
6
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.肺腺癌和肺鳞癌中异常表达的 lncRNAs 和 miRNAs 谱的综合分析及其相关 ceRNA 网络。
Pathol Oncol Res. 2020 Jul;26(3):1935-1945. doi: 10.1007/s12253-019-00780-4. Epub 2020 Jan 2.
7
Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.基于生物信息学分析鉴定肺腺癌中新型预后相关 ceRNA 网络。
Biomed Eng Online. 2021 Nov 24;20(1):117. doi: 10.1186/s12938-021-00952-x.
8
Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.基于RNA测序的ceRNA网络鉴定显示人类肺腺癌中的预后lncRNA生物标志物。
Oncol Lett. 2018 Nov;16(5):5697-5708. doi: 10.3892/ol.2018.9336. Epub 2018 Aug 21.
9
A comprehensive analysis of ncRNA-mediated interactions reveals potential prognostic biomarkers in prostate adenocarcinoma.对非编码RNA介导的相互作用进行的全面分析揭示了前列腺腺癌中潜在的预后生物标志物。
Comput Struct Biotechnol J. 2022 Jul 14;20:3839-3850. doi: 10.1016/j.csbj.2022.07.020. eCollection 2022.
10
Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.构建并综合分析 ceRNA 网络,揭示肺腺癌潜在的预后生物标志物。
BMC Cancer. 2021 Jul 23;21(1):849. doi: 10.1186/s12885-021-08462-8.

引用本文的文献

1
Mutations in tumor signaling, metastases, and synthetic lethality establish distinct patterns.肿瘤信号传导、转移和合成致死性方面的突变呈现出不同的模式。
PLoS Comput Biol. 2025 Aug 4;21(8):e1013351. doi: 10.1371/journal.pcbi.1013351. eCollection 2025 Aug.
2
Eg5 and Diseases: From the Well-Known Role in Cancer to the Less-Known Activity in Noncancerous Pathological Conditions.驱动蛋白样蛋白5(Eg5)与疾病:从其在癌症中的广为人知的作用到在非癌性病理状况下鲜为人知的活性
Biochem Res Int. 2024 Jun 20;2024:3649912. doi: 10.1155/2024/3649912. eCollection 2024.
3
Mitotic Functions and Characters of KIF11 in Cancers.

本文引用的文献

1
Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway.丹参酮 IIA 通过调控 CCNA2-CDK2 复合物和 AURKA/PLK1 通路抑制肺腺癌的进展。
Sci Rep. 2021 Dec 8;11(1):23681. doi: 10.1038/s41598-021-03166-2.
2
Prognostic Impact and Functional Annotations of KIF11 and KIF14 Expression in Patients with Colorectal Cancer.结直肠癌患者 KIF11 和 KIF14 表达的预后影响和功能注释。
Int J Mol Sci. 2021 Sep 8;22(18):9732. doi: 10.3390/ijms22189732.
3
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.
癌症中KIF11的有丝分裂功能与特征
Biomolecules. 2024 Mar 22;14(4):386. doi: 10.3390/biom14040386.
4
CDCA5-EEF1A1 interaction promotes progression of clear cell renal cell carcinoma by regulating mTOR signaling.CDCA5与EEF1A1的相互作用通过调节mTOR信号通路促进肾透明细胞癌的进展。
Cancer Cell Int. 2024 Apr 24;24(1):147. doi: 10.1186/s12935-024-03330-4.
5
Cyclovirobuxine D inhibits growth and progression of non‑small cell lung cancer cells by suppressing the KIF11‑CDC25C‑CDK1‑CyclinB1 G/M phase transition regulatory network and the NFκB/JNK signaling pathway.环维黄杨星 D 通过抑制 KIF11-CDC25C-CDK1-CyclinB1 G/M 期转换调控网络和 NFκB/JNK 信号通路抑制非小细胞肺癌细胞的生长和进展。
Int J Oncol. 2023 May;62(5). doi: 10.3892/ijo.2023.5505. Epub 2023 Mar 17.
clusterProfiler 4.0:用于解释组学数据的通用富集工具。
Innovation (Camb). 2021 Jul 1;2(3):100141. doi: 10.1016/j.xinn.2021.100141. eCollection 2021 Aug 28.
4
Construction and Analysis of a circRNA-Mediated ceRNA Network in Lung Adenocarcinoma.肺腺癌中circRNA介导的ceRNA网络的构建与分析
Onco Targets Ther. 2021 Jun 8;14:3659-3669. doi: 10.2147/OTT.S305030. eCollection 2021.
5
Vascular endothelial cell-derived exosomal miR-30a-5p inhibits lung adenocarcinoma malignant progression by targeting CCNE2.血管内皮细胞衍生的外泌体 miR-30a-5p 通过靶向 CCNE2 抑制肺腺癌恶性进展。
Carcinogenesis. 2021 Aug 19;42(8):1056-1067. doi: 10.1093/carcin/bgab051.
6
GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA.GEPIA2021:将多种基于去卷积的分析整合到 GEPIA 中。
Nucleic Acids Res. 2021 Jul 2;49(W1):W242-W246. doi: 10.1093/nar/gkab418.
7
Effect of miR-30a-5p on Apoptosis, Colonization, and Oxidative Stress Variables in Frozen-Thawed Neonatal Mice Spermatogonial Stem Cells.miR-30a-5p 对冻融新生小鼠精原干细胞凋亡、定植和氧化应激变量的影响。
Biopreserv Biobank. 2021 Aug;19(4):258-268. doi: 10.1089/bio.2020.0121. Epub 2021 Apr 28.
8
The relationship between LncRNAs and lung adenocarcinoma as well as their ceRNA network.LncRNAs 与肺腺癌的关系及其 ceRNA 网络。
Cancer Biomark. 2021;31(2):165-176. doi: 10.3233/CBM-203078.
9
Expression and prognostic value of , , and gene clusters in human breast cancer.人乳腺癌中 、 和 基因簇的表达及预后价值 。 (原文中未明确给出具体基因名称,用“ ”代替)
J Int Med Res. 2021 Apr;49(4):300060520980647. doi: 10.1177/0300060520980647.
10
Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer.综合分析确定CCNA2为乳腺癌免疫治疗的潜在生物标志物。
Onco Targets Ther. 2021 Apr 9;14:2433-2448. doi: 10.2147/OTT.S296373. eCollection 2021.